Table 2A.
Comparison of actual and predicted mortality in the treatment of methylprednisolone pulse.
| SCORTEN | Predicted mortality, % | Patients, n | Predicted death | Actual death |
|---|---|---|---|---|
| 0–1 | 3.2% | 12 | 0.38 | 0 |
| 2 | 12.1% | 14 | 1.69 | 0 |
| 3 | 35.3% | 13 | 4.59 | 1 |
| 4 | 58.3% | 3 | 1.75 | 2 |
| ≥ 5 | 90.0% | 1 | 0.90 | 0 |
| Total | 43 | 9.32 | 3 | |
| SMR | 0.32 |
The comparison of actual and predicted mortality rates associated with the treatment of TEN showed the predicted mortality to be 9.32 cases (21.7%) in all patients and the actual mortality to be three cases (6.98%). In this study, there were no significant differences between predicted and actual mortality (p = 0.1017, X2 test with Yates' continuity correction). SMR, standardized mortality ratio.